. They identified which the focus of HBsAg secreted in the mobile tradition and mouse serum was reduced by CRISPR/Cas9 procedure. They concluded that a CRISPR/Cas9 procedure inhibited HBV replication and expression in vitro As well as in vivoIn addition, this process could inactivate the mutation of residual viral DNA. They concluded that CRISPR/Ca